Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 8 EP applications Charlotte Retzler has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14180875

Pharmaceutical composition containing botulinum neurotoxin A2

IPC classification:
A61K 8/99, A61K 9/00, A61K 38/48, A61K 47/26, A61P 1/00, A61P 5/00, A61P 11/00, A61P 13/00, A61P 17/00, A61P 21/00, A61P 25/14, A61P 27/00, A61P 29/00, A61P 37/00, A61Q 7/00, A61Q 19/08
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
PATENT GRANTED
EP13290175

Aqueous sustained release compositions of LHRH analogs

IPC classification:
A61K 9/00, A61K 38/09, A61K 47/02
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
APPLICATION REFUSED
EP15000178

Pharmaceutical compositions comprising botulinum neurotoxin

IPC classification:
A61K 9/00, A61K 9/19, A61K 38/48, A61K 47/26, A61K 47/30
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
GRANT OF PATENT INTENDED
EP13900760

NOVEL IMIDAZOLIDINE-2, 4-DIONE DERIVATIVES

IPC classification:
A61K 31/4166, A61P 35/00, C07D 403/06
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
EXAMINATION REQUESTED
EP13900705

NOVEL IMIDAZOLIDINE-2,4-DIONE DERIVATIVES

IPC classification:
A61K 31/4166, A61P 35/00, C07D 403/06, C07D 403/14, C07D 417/06, C07D 417/14
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
EXAMINATION REQUESTED
EP16181468

THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY

IPC classification:
A61K 35/74, A61K 38/16, A61P 25/02, A61P 25/04, A61P 29/00
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Mathys & Squire LLP
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
Request for examination was made
EP16177651

PRODUCTION OF ACTIVATED CLOSTRIDIAL NEUROTOXINS

IPC classification:
A61K 38/48, C07K 14/33, C12P 21/06
Agent:
Mathys & Squire LLP
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
The application has been published
EP16194390

CELLULAR VAMP CLEAVAGE ASSAY

IPC classification:
C12Q 1/37, G01N 33/569
Agent:
Charlotte Retzler, IPSEN PHARMA S.A.S.
Status:
The application has been published

Please Sign in to use this feature